Go to content

Publications

460 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:

  1. Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)

    The National Health Care Institute has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and ...

    Report | 29-03-2018

  2. Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

    The National Health Care Institute carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the ...

    Report | 01-03-2018

  3. Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy

    The National Health Care Institute  carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment ...

    Report | 07-02-2018

  4. Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

    The National Health Care Institute  issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...

    Report | 18-01-2018

  5. Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis

    Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...

    Report | 04-01-2018

  6. Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris

    The motto of the National Health Care Institute is "Taking care of good health care: no more and no less than necessary". Every ...

    Report | 17-12-2017

  7. Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma

    Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

    Report | 07-12-2017

  8. Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

    The National Health Care Institute has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone ...

    Report | 20-10-2017

  9. Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

    Publication | 19-10-2017

  10. Project: ‘ICHOM as an accelerator for outcome information’ - factsheet

    Publication | 19-10-2017

Go to